Cardiac spheroids as promising in vitro models to study the human heart microenvironment.
- Publisher:
- Nature Publishing Group
- Publication Type:
- Journal Article
- Citation:
- Scientific Reports, 2017, 7, (1), pp. 1-12
- Issue Date:
- 2017-08-01
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Polonchuk, L | |
dc.contributor.author | Chabria, M | |
dc.contributor.author | Badi, L | |
dc.contributor.author | Hoflack, J-C | |
dc.contributor.author | Figtree, G | |
dc.contributor.author | Davies, MJ | |
dc.contributor.author |
Gentile, C https://orcid.org/0000-0002-3689-4275 |
|
dc.date.accessioned | 2022-08-25T06:32:59Z | |
dc.date.available | 2017-06-26 | |
dc.date.available | 2022-08-25T06:32:59Z | |
dc.date.issued | 2017-08-01 | |
dc.identifier.citation | Scientific Reports, 2017, 7, (1), pp. 1-12 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | http://hdl.handle.net/10453/160847 | |
dc.description.abstract | Three-dimensional in vitro cell systems are a promising alternative to animals to study cardiac biology and disease. We have generated three-dimensional in vitro models of the human heart ("cardiac spheroids", CSs) by co-culturing human primary or iPSC-derived cardiomyocytes, endothelial cells and fibroblasts at ratios approximating those present in vivo. The cellular organisation, extracellular matrix and microvascular network mimic human heart tissue. These spheroids have been employed to investigate the dose-limiting cardiotoxicity of the common anti-cancer drug doxorubicin. Viability/cytotoxicity assays indicate dose-dependent cytotoxic effects, which are inhibited by the nitric oxide synthase (NOS) inhibitor L-NIO, and genetic inhibition of endothelial NOS, implicating peroxynitrous acid as a key damaging agent. These data indicate that CSs mimic important features of human heart morphology, biochemistry and pharmacology in vitro, offering a promising alternative to animals and standard cell cultures with regard to mechanistic insights and prediction of toxic effects in human heart tissue. | |
dc.format | Electronic | |
dc.language | eng | |
dc.publisher | Nature Publishing Group | |
dc.relation.ispartof | Scientific Reports | |
dc.relation.isbasedon | 10.1038/s41598-017-06385-8 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | Doxorubicin | |
dc.subject.mesh | Endothelial Cells | |
dc.subject.mesh | Fibroblasts | |
dc.subject.mesh | Heart | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Models, Biological | |
dc.subject.mesh | Myocytes, Cardiac | |
dc.subject.mesh | Spheroids, Cellular | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | Doxorubicin | |
dc.subject.mesh | Endothelial Cells | |
dc.subject.mesh | Fibroblasts | |
dc.subject.mesh | Heart | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Models, Biological | |
dc.subject.mesh | Myocytes, Cardiac | |
dc.subject.mesh | Spheroids, Cellular | |
dc.subject.mesh | Heart | |
dc.subject.mesh | Spheroids, Cellular | |
dc.subject.mesh | Fibroblasts | |
dc.subject.mesh | Endothelial Cells | |
dc.subject.mesh | Myocytes, Cardiac | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Doxorubicin | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | Models, Biological | |
dc.title | Cardiac spheroids as promising in vitro models to study the human heart microenvironment. | |
dc.type | Journal Article | |
utslib.citation.volume | 7 | |
utslib.location.activity | England | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering | |
pubs.organisational-group | /University of Technology Sydney/Centre for Health Technologies (CHT) | |
utslib.copyright.status | open_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2022-08-25T06:32:52Z | |
pubs.issue | 1 | |
pubs.publication-status | Published | |
pubs.volume | 7 | |
utslib.citation.issue | 1 |
Abstract:
Three-dimensional in vitro cell systems are a promising alternative to animals to study cardiac biology and disease. We have generated three-dimensional in vitro models of the human heart ("cardiac spheroids", CSs) by co-culturing human primary or iPSC-derived cardiomyocytes, endothelial cells and fibroblasts at ratios approximating those present in vivo. The cellular organisation, extracellular matrix and microvascular network mimic human heart tissue. These spheroids have been employed to investigate the dose-limiting cardiotoxicity of the common anti-cancer drug doxorubicin. Viability/cytotoxicity assays indicate dose-dependent cytotoxic effects, which are inhibited by the nitric oxide synthase (NOS) inhibitor L-NIO, and genetic inhibition of endothelial NOS, implicating peroxynitrous acid as a key damaging agent. These data indicate that CSs mimic important features of human heart morphology, biochemistry and pharmacology in vitro, offering a promising alternative to animals and standard cell cultures with regard to mechanistic insights and prediction of toxic effects in human heart tissue.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph